home based biz

468 x 60

Reverbnation

J.J.Sowers

Thursday, January 23, 2014

BioLineRx receives Orphan Drug Designation

BioLineRx receives Orphan Drug Designation for novel stem cell mobilization treatment; BL-8040 expected to commence Phase 1 trial in stem cell mobilization in Q2 2014; top-line results expected in H2 2014.

No comments:

Post a Comment